Clinical Trial Update: Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma [NA]

View source ↗

Summary

This clinical trial update reports safety and preliminary activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• VCN-01

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Retinoblastoma, Recurrent | NA | Status: COMPLETED